Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Regenxbio Inc
NASDAQ:RGNX
Regenxbio Inc
NASDAQ:RGNX
Price:
7.635
USD
1.39%
Market Cap:
$483.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Regenxbio Inc
NASDAQ:RGNX
|
US |
|
T
|
The Born Korea Co Ltd
KRX:475560
|
KR |
|
GPM Metals Inc
XTSX:GPM
|
CA |
Wall St Price Targets
RGNX Price Forecast
Based on 14 analysts
Based on 14 analysts
+167% Upside
from
$7.635
today
Regenxbio Inc (RGNX)’s 12-month stock price forecast through October 2027 has a consensus target of $20.4, implying 167% upside. The forecast is based on price targets from 14 Wall Street analysts.
RGNX Analyst Rating
Based on 12 analysts
Based on 12 analysts
Analysts rate RGNX Buy, with 11 of 12 recommending Buy or Strong buy.
Regenxbio Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RGNX's stock price target?
Price Target
20.4
USD
20.4
USD
According to Wall Street analysts, the average 1-year price target for RGNX is 20.4 USD with a low forecast of 10.1 USD and a high forecast of 52.5 USD.
What is the Revenue forecast for Regenxbio Inc?
Projected CAGR
30%
30%
Over the last 11 years, the compound annual growth rate for Revenue has been 35%. The projected CAGR for the next 8 years is 30%.
What is the Gross Profit forecast for Regenxbio Inc?
Projected CAGR
30%
30%
Over the last 11 years, the compound annual growth rate for Gross Profit has been 36%. The projected CAGR for the next 8 years is 30%.